rs1060500142
Variant summary
Our verdict is Pathogenic. Variant got 17 ACMG points: 17P and 0B. PM1PM2PP2PP3_StrongPP5_Very_Strong
The NM_001035.3(RYR2):c.230C>T(p.Ala77Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,686 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. A77A) has been classified as Likely benign.
Frequency
Consequence
NM_001035.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RYR2 | NM_001035.3 | c.230C>T | p.Ala77Val | missense_variant | 3/105 | ENST00000366574.7 | NP_001026.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RYR2 | ENST00000366574.7 | c.230C>T | p.Ala77Val | missense_variant | 3/105 | 1 | NM_001035.3 | ENSP00000355533.2 | ||
RYR2 | ENST00000609119.2 | n.230C>T | non_coding_transcript_exon_variant | 3/104 | 5 | ENSP00000499659.2 | ||||
RYR2 | ENST00000660292.2 | c.230C>T | p.Ala77Val | missense_variant | 3/106 | ENSP00000499787.2 | ||||
RYR2 | ENST00000659194.3 | c.230C>T | p.Ala77Val | missense_variant | 3/105 | ENSP00000499653.3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249222Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135198
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461686Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727126
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 02, 2023 | Published in one family and segregated with both CPVT and ARVC in several relatives (d'Amati et al., 2005); Not observed at significant frequency in large population cohorts (gnomAD); Published functional studies demonstrate a damaging effect as this variant may affect calcium release, which is thought to cause arrhythmia (Tang et al., 2012); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Is located in one of the three hot-spot regions of the RYR2 gene, where the majority of pathogenic missense variants occur (Medeiros-Domingo et al., 2009); This variant is associated with the following publications: (PMID: 24025405, 19913485, 22221940, 16084945, 25901278, 31112425, 22374134) - |
Catecholaminergic polymorphic ventricular tachycardia 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 12, 2023 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects RYR2 function (PMID: 19913485, 22374134). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RYR2 protein function. ClinVar contains an entry for this variant (Variation ID: 404190). This missense change has been observed in individuals with arrhythmogenic right ventricular cardiomyopathy (ARVC), and catecholaminergic polymorphic ventricular tachycardia (CPVT) (PMID: 16084945; Invitae). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (no rsID available, gnomAD 0.0009%). This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 77 of the RYR2 protein (p.Ala77Val). - |
Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 11, 2019 | The p.A77V variant (also known as c.230C>T), located in coding exon 3 of the RYR2 gene, results from a C to T substitution at nucleotide position 230. The alanine at codon 77 is replaced by valine, an amino acid with similar properties. This variant has been reported in a sudden death case with an arrhythmogenic right ventricular cardiomyopathy phenotype on autopsy and in two relatives with catecholaminergic polymorphic ventricular tachycardia (CPVT) as well as in an aborted cardiac arrest patient with CPVT (d'Amati G et al. Hum. Pathol., 2005 Jul;36:761-7; van der Werf C et al. Heart Rhythm, 2010 Oct;7:1383-9). Functional studies suggest this alteration impacts calcium signaling, but the physiological relevance of this impact is unclear (Tang Y. et al. Circ. Res., 2012 Mar;110(7):968-77). Based on internal structural analysis, this variant is anticipated to result in a significant decrease in structural stability (Lobo PA et al. Structure, 2009 Nov;17:1505-14; Tung CC et al. Nature, 2010 Nov;468:585-8; Walpoth BN et al. F1000Res, 2015 Jan;4:29). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at